Locations:
Search IconSearch

Image of Note: 3-D Radiation-Free Navigation of the Aorta

Endovascular navigation technology clears first preclinical study

Centerline Biomedical IOPS

Endovascular repair of aortic aneurysms and dissections is critically dependent on optimal understanding of the patient’s vasculature. To that end, Cleveland Clinic Innovations spinoff company Centerline Biomedical Inc. is refining development of its Intraoperative Positioning System (IOPS), a novel endovascular navigation technology developed by Cleveland Clinic researchers.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

IOPS extracts the centerlines of the aorta and branch vessels from a patient’s CT and then mathematically constructs a high-quality three-dimensional model of the relevant vasculature, as shown in the image above. Electromagnetic tracking technology allows the model to be used in a GPS-like fashion to guide surgeons during minimally invasive endovascular aortic repairs, enabling less reliance on X-ray fluoroscopy.

The first preclinical in vivo study of IOPS was completed in May 2016 at Cleveland Clinic Lerner Research Institute. It demonstrated the system’s ability to provide non-radiation-based navigation with superior visualization compared with X-ray fluoroscopy, which is limited by its two-dimensional visualization and by the radiation exposure it confers on patients and providers.

“Preclinical evaluation verified the ability to use this navigation system in manipulating through the aorta and its branches in the absence of radiation-inducing fluoroscopy,” says Cleveland Clinic vascular surgeon Matthew Eagleton, MD, who led the study. Noting that catheters and guidewires were easily visualized on the IOPS display, he predicted that the system “will be a game changer in the era of endovascular therapy.”

Centerline Biomedical plans to submit IOPS for FDA review, with a target market entry in the third quarter of 2017.

Advertisement

Related Articles

illustration of heart and lungs with text next to it

Vital Statistics in Adult Cardiac Surgery, Including Valve and Aorta Operations

An infographic-style overview of our volumes and outcomes

Heart with DNA helix

First-in-Human Gene Therapy for HCM Demonstrates Safety and Early Efficacy

Initial data indicate tolerability and promising cardiac remodeling effects

male doctor working at laptop with a high-tech algorithmic overlay

AI Can Reliably Unlock EHR Data to Determine Clinical Trial Eligibility, Study Finds

LLM-driven system uses both structured and unstructured data, provides auditable justifications

Young adult having heart exam

Addressing the Unique Needs of Young Adults With Congenital or Inherited Heart Disease

A new CME opportunity in Chicago, May 15-16

illustration of heart showing arterial grafts

Cardiac Revascularization: What’s Been Learned Over 40 Years of IMA-to-LAD Grafting?

After four decades, refinements to the gold standard of bypass continue as new insights emerge

surgical team in an operating room with a podcast button overlay

Progress in Treating Ventricular Septal Rupture After Myocardial Infarction (Podcast)

Why definitive surgical closure is the gold standard, and new ways to make it possible

illustration of human heart with a graft repair

Novel Technique for Aortic Stenosis and Patient-Prosthesis Mismatch With LVOT Obstruction

Modified-Bentall single-patch Konno enlargement (BeSPoKE) optimizes hemodynamics, facilitates future TAVR

red blood cells floating around a DNA double helix

CHIP Cardiology Clinics Are Needed as CHIP Diagnoses Rise

Cleveland Clinic’s new dedicated program offers nuanced care for a newly recognized cardiovascular risk factor

Ad